🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8344019

Methods for the production of biliverdin

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337831

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337854

Monoclonal antibodies against dengue and other viruses with deletion in Fc region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337853

Monoclonal antibodies that bind or neutralize dengue virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337832

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323961

HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318666

Use of leptin to treat metabolic abnormalities associated with lipoatrophy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318177

Viral chemokine-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8309527

Immunomodulatory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8303960

Radiolabeled affibody molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8299050

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298541

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293800

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the tre

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293724

Therapeutic applications of fatty acid amide hydrolase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative l

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288439

Methods and compositions for the inhibition of HIV-1 replication

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283151

Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278272

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273724

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268894

Compositions and methods for the treatment of infectious diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268602

Cellular and viral inactivation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263759

Sets of probes and primers for the diagnosis of select cancers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258278

Methods and compositions for the treatment and prevention of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252545

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted